Evidence map›Paper›PMID 41281606›Full record

ReviewFrontiers in radiology2025

Self-supervised learning and transformer-based technologies in breast cancer imaging.

Lulu Wang

Abstract readReview
In one paragraph

Review in Frontiers in radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lulu WangDepartment of Engineering, Reykjavik University, Reykjavik, Iceland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common malignancy among women worldwide, and imaging remains critical for early detection, diagnosis, and treatment planning. Recent advances in artificial intelligence (AI), particularly self-supervised learning (SSL) and transformer-based architectures, have opened new opportunities for breast image analysis. SSL offers a label-efficient strategy that reduces reliance on large annotated datasets, with evidence suggesting that it can achieve strong performance. Transformer-based architectures, such as Vision Transformers, capture long-range dependencies and global contextual information, complementing the local feature sensitivity of convolutional neural networks. This study provides a comprehensive overview of recent developments in SSL and transformer models for breast lesion segmentation, detection, and classification, highlighting representative studies in each domain. It also discusses the advantages and current limitations of these approaches and outlines future research priorities, emphasizing that successful clinical translation depends on access to multi-institutional datasets to ensure generalizability, rigorous external validation to confirm real-world performance, and interpretable model designs to foster clinician trust and enable safe, effective deployment in clinical practice.

Indexed as

artificial intelligencebreast cancermedical imagingself-supervised learningtransformers

Identifiers

PMID41281606
PMCPMC12634322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.